MALE Mamm Organoids
ConditionBreast Neoplasms, Male
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorRegina Elena Cancer Institute
About this trial
It is believed that the use of organoids derived from male breast tumors can be of fundamental support for the definition of the molecular mechanisms underlying the onset of the tumor. Furthermore, the development of such preclinical models could be of significant support for the identification of specific personalized and ad hoc therapeutic treatments for male pathology.
Eligibility criteria
Qualifiers
Men aged >18 years
Patients with histologically confirmed breast cancer with or without synchronous metastases, who will undergo the relevant surgical intervention
Adequate biological material to be able to carry out the analyses described above
Signing of the relevant informed consent form
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Regina Elena Cancer Institute
Lead sponsor
San Giovanni Addolorata Hospital
Collaborator
Weizmann Institute of Science, Israel
Collaborator
S. Andrea Hospital
Collaborator
Source ClinicalTrials.gov